{"nct_id":"NCT06063967","title":"A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2023-11-15","start_date_type":"ACTUAL","primary_completion_date":"2027-03","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}